Literature DB >> 12850686

Patients with Crohn's disease are unaware of the risks that smoking has on their disease.

William R Ryan1, Catherine Ley, Robert N Allan, Michael R B Keighley.   

Abstract

Smoking, both in quantity and duration, increases the risk of recurrent Crohn's disease (CD) and the need for surgical treatment of CD. This study assessed awareness among patients with CD of the risks of smoking on their disease. We distributed self-administered questionnaires to 714 CD patients under follow-up at the University Hospital Birmingham, United Kingdom. We asked the patients eight multiple-choice (yes/uncertain/no) questions about the effects of smoking on health and on CD. We also determined relevant patient demographics, smoking history, and medical history. A total of 312 patients completed the questionnaire. Patients acknowledged the dangers of smoking on overall health (91.5%), lung cancer (89.6%), lung disease (90.8%), and cardiovascular disease (85.3%). Employed, educated, and homeowning patients demonstrated significantly more recognition of these smoking risks. Conversely, few patients recognized that smoking increases the risks of development of CD (9.5%) and of reoperation for CD (12.0%). Moreover, few patients recognized that both the quantity of cigarettes smoked (11.4%) and the duration of smoking (17.4%) increase the risk of reoperation. Patients with CD are unaware of the risks that smoking has on their disease, indicating a need for increased patient education with regard to the effects of smoking on CD.

Entities:  

Mesh:

Year:  2003        PMID: 12850686     DOI: 10.1016/s1091-255x(03)00066-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  18 in total

1.  The association of cigarette smoking with a high risk of recurrence after ileocolonic resection for ileocecal Crohn's disease.

Authors:  T Yamamoto; M R Keighley
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Risk factors for surgery and postoperative recurrence in Crohn's disease.

Authors:  O Bernell; A Lapidus; G Hellers
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group.

Authors: 
Journal:  Aliment Pharmacol Ther       Date:  1990-02       Impact factor: 8.171

4.  Smoking habits and recurrence in Crohn's disease.

Authors:  M Cottone; M Rosselli; A Orlando; L Oliva; A Puleo; M Cappello; M Traina; F Tonelli; L Pagliaro
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

5.  Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease.

Authors:  C Prantera; F Pallone; G Brunetti; M Cottone; M Miglioli
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

6.  Long-term outcome of total colectomy and ileostomy for Crohn disease.

Authors:  T Yamamoto; M R Keighley
Journal:  Scand J Gastroenterol       Date:  1999-03       Impact factor: 2.423

7.  Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.

Authors:  B Landi; T N Anh; A Cortot; J C Soule; E Rene; J P Gendre; P Bories; A See; E H Metman; C Florent
Journal:  Gastroenterology       Date:  1992-05       Impact factor: 22.682

Review 8.  Adjuvant post-operative therapy.

Authors:  K Leiper; I London; J M Rhodes
Journal:  Baillieres Clin Gastroenterol       Date:  1998-03

9.  Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group.

Authors:  M G Russel; A Volovics; E J Schoon; E H van Wijlick; R F Logan; S Shivananda; R W Stockbrügger
Journal:  Inflamm Bowel Dis       Date:  1998-08       Impact factor: 5.325

Review 10.  Surgical therapy for Crohn's disease.

Authors:  P E Shorb
Journal:  Gastroenterol Clin North Am       Date:  1989-03       Impact factor: 3.806

View more
  7 in total

Review 1.  Management of Crohn's disease in smokers: is an alternative approach necessary?

Authors:  Pilar Nos; Eugeni Domènech
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

Review 2.  Predicting, treating and preventing postoperative recurrence of Crohn's disease: the state of the field.

Authors:  Anna M Borowiec; Richard N Fedorak
Journal:  Can J Gastroenterol       Date:  2011-03       Impact factor: 3.522

Review 3.  Factors affecting recurrence after surgery for Crohn's disease.

Authors:  Takayuki Yamamoto
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

Review 4.  The impact of smoking in Crohn's disease: no smoke without fire.

Authors:  Marian C Aldhous; J Satsangi
Journal:  Frontline Gastroenterol       Date:  2010-09-23

5.  Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study.

Authors:  Tiago Nunes; Maria Josefina Etchevers; Valle García-Sánchez; Daniel Ginard; Eva Martí; Manuel Barreiro-de Acosta; Fernando Gomollón; Maite Arroyo; Guillermo Bastida; Benito Gonzalez; David Monfort; Esther García-Planella; Carolina Figueroa; Julián Panés; Miquel Sans
Journal:  Am J Gastroenterol       Date:  2016-02-09       Impact factor: 10.864

6.  Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.

Authors:  Catherine Le Berre; Laura Loy; Sanna Lönnfors; Luisa Avedano; Daniele Piovani
Journal:  World J Gastroenterol       Date:  2020-08-07       Impact factor: 5.742

7.  The effect of a multidisciplinary approach for smoking cessation in patients with Crohn's disease: Results from an observational cohort study.

Authors:  Pierachille Santus; Dejan Radovanovic; Davide Raiteri; Stefano Pini; Giuseppe Spagnolo; Giovanni Maconi; Maurizio Rizzi
Journal:  Tob Induc Dis       Date:  2020-04-02       Impact factor: 2.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.